These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Takeda K; Ichiki T; Tokunou T; Iino N; Fujii S; Kitabatake A; Shimokawa H; Takeshita A Arterioscler Thromb Vasc Biol; 2001 May; 21(5):868-73. PubMed ID: 11348889 [TBL] [Abstract][Full Text] [Related]
23. Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes. Marutsuka K; Woodcock-Mitchell J; Sakamoto T; Sobel BE; Fujii S Coron Artery Dis; 1998; 9(4):177-84. PubMed ID: 9649923 [TBL] [Abstract][Full Text] [Related]
24. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I. Imai Y; Clemmons DR Endocrinology; 1999 Sep; 140(9):4228-35. PubMed ID: 10465296 [TBL] [Abstract][Full Text] [Related]
25. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts. Tong L; Smyth D; Kerr C; Catterall J; Richards CD Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007 [TBL] [Abstract][Full Text] [Related]
26. The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart. Weiss TW; Kvakan H; Kaun C; Zorn G; Speidl WS; Pfaffenberger S; Maurer G; Huber K; Wojta J J Mol Cell Cardiol; 2005 Sep; 39(3):545-51. PubMed ID: 15890357 [TBL] [Abstract][Full Text] [Related]
27. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426 [TBL] [Abstract][Full Text] [Related]
28. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2. Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430 [TBL] [Abstract][Full Text] [Related]
29. Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitor. Mirshahi F; Vasse M; Tedgui A; Li H; Merval R; Legrand E; Vannier JP; Soria J; Soria C Blood Coagul Fibrinolysis; 2002 Jul; 13(5):449-55. PubMed ID: 12138373 [TBL] [Abstract][Full Text] [Related]
30. Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia. Bellik L; Vinci MC; Filippi S; Ledda F; Parenti A Br J Pharmacol; 2005 Oct; 146(4):568-75. PubMed ID: 16086034 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. Chandrasekar B; Mummidi S; Mahimainathan L; Patel DN; Bailey SR; Imam SZ; Greene WC; Valente AJ J Biol Chem; 2006 Jun; 281(22):15099-109. PubMed ID: 16554298 [TBL] [Abstract][Full Text] [Related]
32. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1. Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897 [TBL] [Abstract][Full Text] [Related]
33. Adropin is a novel regulator of endothelial function. Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta M; Al-Omran M; Teoh H; Verma S Circulation; 2010 Sep; 122(11 Suppl):S185-92. PubMed ID: 20837912 [TBL] [Abstract][Full Text] [Related]
34. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor. Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320 [TBL] [Abstract][Full Text] [Related]